Results 141 to 150 of about 31,861 (267)

Optimizing Oligonucleotide Therapeutics: A Model‐Informed Drug Development Perspective

open access: yesClinical and Translational Science, Volume 19, Issue 5, May 2026.
ABSTRACT Oligonucleotide therapies have emerged as a powerful therapeutic class, providing novel solutions for diverse diseases through antisense oligonucleotides (ASOs), small interfering RNAs (siRNAs), and aptamers that specifically target and modulate gene expression or protein function. However, oligonucleotide development faces distinct challenges,
Ye Yuan   +7 more
wiley   +1 more source

The Role of NLRP1, AIM2 and MEFV Inflammasomes in the High‐Intensity Interval Training of Individuals With Obesity

open access: yesImmunology, Volume 178, Issue 1, Page 109-117, May 2026.
This study shows that 8 weeks of high‐intensity interval training (HIIT) modulate inflammasome‐related gene expression in individuals with obesity. HIIT increased AIM2, MEFV, CARD16 and CARD18 expression, with CARD16 upregulation supporting reduced inflammation through inhibition of caspase‐1 activation and lower IL‐1β levels.
Ana Luíza Pereira Assunção Silveira   +8 more
wiley   +1 more source

A Systemic Juvenile Idiopathic Arthritis Patient with Reduced Anakinra Treatment Admitted with an Attack

open access: diamond, 2016
Dilek Yılmaz   +4 more
openalex   +1 more source

Epstein-Barr virus associated haemophagocytic lymphohistiocytosis treated with anakinra and rituximab: A case report

open access: gold, 2020
Naina McCann   +6 more
openalex   +1 more source

Cardiometabolic effects of genetic upregulation of the interleukin 1 receptor antagonist: a Mendelian randomisation analysis. [PDF]

open access: yes, 2015
BACKGROUND: To investigate potential cardiovascular and other effects of long-term pharmacological interleukin 1 (IL-1) inhibition, we studied genetic variants that produce inhibition of IL-1, a master regulator of inflammation.
Interleukin 1 Genetics Consortium
core  

Paraneoplastic Lupus Nephritis in a Child With Neuroblastoma Recurrence

open access: yes
Pediatric Blood &Cancer, Volume 73, Issue 5, May 2026.
Gabriele Mortari   +9 more
wiley   +1 more source

Author Correction: Anakinra in Sanfilippo syndrome: a phase 1/2 trial [PDF]

open access: hybrid
Lynda E. Polgreen   +9 more
openalex   +1 more source

Anakinra Drug Retention Rate and Predictive Factors of Long-Term Response in Systemic Juvenile Idiopathic Arthritis and Adult Onset Still Disease [PDF]

open access: gold, 2019
Jurgen Sota   +32 more
openalex   +1 more source

The efficacy of anakinra compared to standard care of treatment for COVID-19: a metaanalysis

open access: bronze, 2022
HAMNA MALIK   +5 more
openalex   +2 more sources

Home - About - Disclaimer - Privacy